HTGM Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 jun 2023 @ 22:00):

Stats
Dagens volum	725 429
Gjennomsnittsvolum	253 915
Markedsverdi	1.06M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0281
ATR14	$0.314 (65.42%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-08	Barat Stephen	Sell	888	Common Stock
2023-03-31	Barat Stephen	Sell	52	Common Stock
2023-02-02	Barat Stephen	Sell	0	Common Stock
2023-02-02	Barat Stephen	Sell	4 166	Stock Option (right to buy)
2023-02-02	Barat Stephen	Sell	2 083	Stock Option (right to buy)

INSIDER POWER
93.71
Last 98 transactions
Buy: 3 245 171 \| Sell: 16 674

Volum Korrelasjon

Lang: 0.10 (neutral)

Kort: -0.53 (weak negative)

Signal:(18.674) Neutral

HTG Molecular Diagnostics Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

HTG Molecular Diagnostics Korrelasjon - Valuta/Råvare

0.64
( weak )

0.73
( moderate )

0.00
( neutral )

0.75
( moderate )

-0.12
( neutral )

-0.75
( moderate negative )

HTG Molecular Diagnostics Økonomi

Annual	2022
Omsetning:	$6.37M
Bruttogevinst:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2022
Omsetning:	$6.37M
Bruttogevinst:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2021
Omsetning:	$8.91M
Bruttogevinst:	$716 868 (8.05 %)
EPS:	$-0.206

FY	2020
Omsetning:	$8.55M
Bruttogevinst:	$4.56M (53.31 %)
EPS:	$-0.376

Financial Reports:

No articles found.

HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.